Novovax COVID vaccine shown to be 89.3% effective in phase 3 trials January 29, 2021 Auto Bot News 0 The Novovax COVID-19 vaccine, which the UK government has pre-ordered 60m doses of, has been shown to be 89.3% effective in data published from its phase 3 clinical trial.